Check 35,000+ stocks against 26 valuation models and 37 quality factors

Transcat Inc (TRNS) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Transcat Inc $11.18, price $89.05, upside -87.5%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? No
Add to watchlist

Industrials · US · ISIN US8935291075

Thin data Sep 23, 2026

Transcat Inc

TRNS · US

Structural break: The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.

Weakest SetupStrongly overvalued and low quality.

!Fair value $11.18 · Strongly overvalued (−87%)

!Quality 42/100

!Mixed Growth (revenue 5y +13.9 %/yr)

!Thin margins · 1.6% net margin (TTM)

✓Low debt · generates free cash flow

!Trails peers (1/13)

!Narrow moat 32/100

!Evidence only low, so the estimate is less certain

!Weak on past: 7 out of 100

26 models, one by oneBear $10.08 to bull $15.11 Growth analysisrevenue history, year by year Quality 42/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Transcat Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $51.52 – $144.07 · fair‑value band $10.08 – $15.11 · the $89.05 price screens above the $11.18 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Transcat in your weekly email

Every Wednesday you see whether Transcat is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. The company operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

Stock analysis

Transcat Inc (TRNS) currently trades at $89.05, while our model-based Fair Value estimate is $11.18, implying the stock looks roughly 696.8% overvalued today.

Valuation

Bull case: the Asset-Based group reads highest at a median of $21.56 per share, and 0 of the 24 models we run sit above the $89.05 price.

Bear case: the Earnings-Based group reads lowest at $4.58, and 24 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: $10.08 (bear) to $15.11 (bull), the price of $89.05 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Transcat Inc reported revenue of $332M in FY2026 versus $205M in FY2022, a compound +12.8%/yr. Reported net income was $5.4M in FY2026, compounding −17.1%/yr from FY2022.

Key figures

Market cap $831M · P/E ratio 156.2 · P/S ratio 2.53 · EPS (TTM) $0.5700 · Net margin 1.6% · Return on equity 1.8% · Return on assets (EBIT) 6.1% · Operating margin 6.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 9% below its 52-week high and 71% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 0% fair-value upside, at −87%, TRNS screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely ($0.2000 to $44.72). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.

Bear $10.08 Fair Value $11.18 Bull $15.11

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then ($0.2764 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF $14.50 $26.85 $43.92 78

Growth DCF $14.52 $25.01 $38.47 77

Owner Earnings $11.08 $21.71 $36.41 74

All 24 models by family

DCF Models

FCF DCF $14.50 $26.85 $43.92 78

Owner Earnings $11.08 $21.71 $36.41 74

5Y Revenue Exit $7.01 $15.18 $25.41 70

5Y EBITDA Exit $21.80 $43.53 $69.35 73

5Y P/E Exit $4.43 $10.22 $16.19 68

10Y Revenue Exit $9.44 $17.35 $27.77 65

10Y EBITDA Exit $18.49 $35.58 $59.12 66

10Y P/E Exit $8.26 $14.17 $21.19 63

Earnings-Based

Graham-Dodd $3.91 $13.74 $18.48 64

Lynch FV $3.21 $4.58 $5.96 61

PEG = 1.0 $3.21 $4.58 $5.96 57

EPV n/a $0.2000 $1.24 68

Multiples

P/E Multiple $9.06 $12.09 $15.11 63

P/S Multiple $7.34 $9.78 $12.23 58

P/B Multiple $7.34 $9.78 $12.23 55

EV/EBIT $7.94 $13.97 $20.01 64

EV/EBITDA $31.00 $44.72 $58.44 67

EV/Revenue $2.76 $8.29 $13.83 49

Asset-Based

NCAV (Graham) $16.09 $21.56 $32.18 54

Growth DCF

Growth DCF $14.52 $25.01 $38.47 77

Rev-Margin DCF $7.01 $15.42 $25.51 70

Economic Profit

Residual Income $21.13 $19.47 $13.84 71

ROIC Compounder n/a $0.2000 $1.24 68

Growth Earnings

Growth-Adj P/E $7.83 $11.18 $14.54 67

Open the full fair value analysis →

Notify me when TRNS reaches fair value

Put TRNS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 42/100

Of which business quality 46 · Market factors (momentum, volatility) 59

Profitability 30

Margins and returns on capital today

Quality Growth 45

Are margins and returns improving?

Cashflow 54

Earnings quality: real cash, not paper profit

Fin. Strength 66

Balance sheet, leverage, solvency risk

Investment 29

Disciplined investing over empire-building

Low Volatility 57

Calm price path (market factor)

Momentum 56

Price trend over the last 3–12 months (market factor)

52W Momentum 68

Distance to the 52-week high (market factor)

Net Issuance 41

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 85/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+19.2%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+12.9%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+13.9%

Start year 2021 (pandemic). Over 10 years: +10.5% a year

Revenue growth 39 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+8.2%

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

’26

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

−11.8%

Earnings growth per share plus dividend.

Earnings per share, growth per year−11.8%

Dividend (yield on the price)0.0%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−12% vs 0%, slowing

Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 4%

Start year 2021 (pandemic)

Growth Forecast

A lot of optimism in the price

The price assumes more growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+27.9%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+6.5%

Yearly sales growth analysts expect, extended to five years.

After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +25.0% a year for the price and +4.0% for the forecasts.

Forecast 2027 (sales)+9.1%

Forecast 2028 (sales)+6.8%

Projected 2029 (sales)+6.2%

Projected 2030 (sales)+5.6%

Projected 2031 (sales)+5.0%

TRNS screens 697% overvalued. Compare with Cintas Corporation →

Compare Transcat Inc with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 246 stocks

Beats the industry median on 1/13 measures

Overall it trails its industry peers.

Valuation

Quality Score 42 · Bottom 25%

Fair Value upside −87% · Bottom 25%

Profitability

Return on equity (TTM) 2% · Below median

Return on assets 2% · Below median

Net margin (TTM) 2% · Below median

Operating margin (TTM) 6% · Below median

Growth and dividend

Revenue growth 16% · Top 25%

Balance sheet

Debt / equity 0.33× · Above median

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/E (TTM) 156.2× · Priciest 25%

P/B 2.76× · Pricier than median

P/S (TTM) 2.51× · Priciest 25%

P/FCF 42.5× · Priciest 25%

EV/EBITDA 22.1× · Priciest 25%

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 42

FUTURE (revenue growth)79 · sector 28

PAST (return on equity)7 · sector 35

HEALTH (low debt)83 · sector 90

DIVIDEND (yield)0 · sector 52

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
Cintas Corporation CTAS	$198.80	$181.30	−9%
Thomson Reuters Corporation TRI	$95.66	$70.26	−27%
Copart, Inc CPRT	$28.80	$32.23	+12%
Global Payments Inc GPN	$84.78	$85.85	+1%
RB Global, Inc RBA	C$117.34	C$129.07	+10%
UL Solutions Inc ULS	$66.65	$33.62	−50%
Brambles Limited BXB	A$18.73	A$18.66	+0%
Wolters Kluwer N.V WKL	€66.82	€97.78	+46%
Aramark ARMK	$56.59	$23.15	−59%
Rentokil Initial plc RTO	$21.37	$19.63	−8%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Transcat Inc · Fair Value
$11.18 −697%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/TRNS" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Transcat Inc · Fair Value</span><br><b style="font-size:20px">$11.18</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−697%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Transcat Inc Fair Value". https://www.fairvalue-calculator.com/stock/TRNS

Frequently asked questions

Is Transcat Inc (TRNS) overvalued or undervalued?

As of Sep 23, 2026, our model estimates a fair value of $11.18 versus a price of $89.05, about −87% upside (overvalued).

What is the fair value of TRNS?

Our model-based fair value for Transcat Inc is $11.18 (as of Sep 23, 2026), built from audited fundamentals. The current price: $89.05.

What is the quality score of TRNS?

Transcat Inc has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Transcat Inc (TRNS)?

Our model-based price target is the fair value of $11.18 (as of Sep 23, 2026) from 24 valuation models. Cautious scenario $10.08, optimistic scenario $15.11. It is a calculation from audited fundamentals, not an analyst target.

What is the Transcat Inc stock forecast for 2026?

Our models put fair value at $11.18, about −87% upside versus a price of $89.05 (overvalued). Cautious scenario $10.08, optimistic scenario $15.11. The calculation is refreshed regularly with new filings.

What is the revenue of Transcat Inc (TRNS)?

Transcat Inc reported trailing-twelve-month revenue of about $332M (latest available figure, as of Sep 23, 2026).

What growth is priced into Transcat Inc (TRNS)?

For today's price to be fair in a discounted-cash-flow model, Transcat Inc would have to grow free cash flow by +27.9 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.9 % per year. As of Sep 23, 2026.

What discount rate (WACC) does the fair value of TRNS use?

Our models discount Transcat Inc at 10.4 %: a base by market capitalisation (small), damped by beta 0.70, country premium for USA. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Transcat Inc that is +27.9 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.

How much growth has Transcat Inc (TRNS) delivered so far?

Over the past 5 years revenue at Transcat Inc grew +13.9 % a year. The price currently implies +27.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Transcat Inc (TRNS) growing?

The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Transcat Inc (+27.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Transcat Inc (TRNS)?

The free-cash-flow yield on the price is 2.35 %: that much free cash flow Transcat Inc produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Transcat Inc (TRNS)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Transcat Inc it is $11.18 per share (as of Sep 23, 2026), against a price of $89.05. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).

Is Transcat Inc stock overvalued or undervalued in 2026?

As of Sep 23, 2026, TRNS trades above its calculated fair value: price $89.05, fair value $11.18, a gap of about −87% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of TRNS?

No. The price is what the market pays today ($89.05); the fair value is what the company's own numbers justify ($11.18). For Transcat Inc the two are $77.87 per share apart. That gap is exactly why we show both numbers side by side.

How much is Transcat Inc worth?

The market values Transcat Inc at about $831M (market capitalisation, as of Sep 23, 2026). Per share that is $89.05; our models calculate a fair value of $11.18 per share.

What do the bullish and bearish scenarios say about TRNS?

Our models span a range for Transcat Inc: cautious scenario $10.08, base $11.18, optimistic $15.11 per share (as of Sep 23, 2026, price $89.05). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of TRNS?

Transcat Inc trades at a price-to-earnings ratio of 156.2 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $11.18 is built from several models across several years. Other multiples: P/B 2.8, P/S 2.5, EV/EBITDA 22.1.

How solid is the balance sheet of Transcat Inc (TRNS)?

Balance-sheet figures for Transcat Inc (as of Sep 23, 2026): return on equity 1.8%, debt of 0.33 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.

How far is TRNS from its 52-week high?

Transcat Inc trades at $89.05, about 9% below its 52-week high of $97.76 and 71% above the low of $52.06 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $11.18 is for.

Which stocks are comparable to Transcat Inc?

From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Transcat Inc stock attractive at the current price?

The data as of Sep 23, 2026: price $89.05, calculated fair value $11.18 (−87%), Quality Score 42/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of TRNS calculated?

We run Transcat Inc through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $11.18, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.1 % above its aggregate fair value. Transcat Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Transcat Inc (TRNS)?

The closing price on Sep 23, 2026 was $89.05. Our model-based fair value is $11.18, about −87% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Transcat Inc right now?

The price sits above even our optimistic bull case ($15.11). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Where does the earnings growth of Transcat Inc (TRNS) come from?

Earnings per share at Transcat Inc grew +8.5 % a year from 2015 to 2026. Broken into its drivers: revenue per share +6.5 %, EBIT margin +0.9 %, tax rate +1.7 %, residual (interest, one-offs) −0.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Transcat Inc

How large is the market capitalisation of Transcat Inc (TRNS)?

The market capitalisation of Transcat Inc is $831M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Transcat Inc (TRNS)?

The price-to-sales ratio of Transcat Inc is 2.53 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Transcat Inc (TRNS)?

Earnings per share at Transcat Inc are $0.5700 (price ÷ EPS = P/E 156.2). Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Transcat Inc (TRNS)?

The net margin of Transcat Inc is 1.6% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Transcat Inc (TRNS)?

The return on equity (ROE) of Transcat Inc is 1.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Transcat Inc (TRNS)?

On an EBIT basis the return on assets of Transcat Inc is 6.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Transcat Inc (TRNS)?

The operating margin of Transcat Inc is 6.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Transcat Inc (TRNS)?

Revenue at Transcat Inc is growing +15.8% versus a year earlier (3y avg +12.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Transcat Inc (TRNS)?

Earnings per share at Transcat Inc are growing −58.3% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Transcat Inc (TRNS) carry?

The net debt of Transcat Inc is $124M (fiscal year 2026, ≈ 6.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Transcat Inc in the live analysis

One click puts Transcat Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.